课题基金 / 基金详情

Development of Molecular Targeted Disease Modifying Therapy for Polyglutamine Diseases

Development of Molecular Targeted Disease Modifying Therapy for Polyglutamine Diseases
多聚谷氨酰胺疾病分子靶向疾病修饰疗法的发展
批准号:
21229011
负责人:
SOBUE Gen
金额:
$101.59万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (S)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009-05-11 至 2014-03-31

项目摘要

项目成果

SOBUE Gen的其他基金

相似基金

相关文献

中文摘要
翻译
脊髓和球性肌萎缩症(Spinal and bulbar muscular atrophy, SBMA)是一种由雄激素受体(AR)基因CAG三核苷酸扩增引起的运动神经元疾病。突变AR的核积累引发SBMA运动神经元的变性。我们的研究结果表明,自噬在SBMA中起保护作用,一种激活分子伴侣和自噬的小化合物抑制了SBMA中运动神经元的退化。我们还证明,在SBMA小鼠中外源性补充上调的miRNA可以减轻突变ar介导的运动神经元变性。
英文摘要
Spinal and bulbar muscular atrophy (SBMA)is a motor neuron disease caused by an expansion of CAG trinucleotide expansion with in the androgen receptor (AR) gene. Nuclear accumulation of mutant AR triggers the degeneration of motor neurons in SBMA. Our results indicate that autophagy plays a protective role in SBMA, and that a small compound activating both molecular chaperones and autophagy suppresses the motor neuron degeneration in this disease. We also demonstrated that exogenous supplementation of miRNA that is up-regulated in SBMA mice attenuates mutant AR-mediated motor neuron degeneration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/jnc.12172
发表时间: 2013-07
期刊: Journal of Neurochemistry
影响因子: 4.7
作者: [Qiang Qiang-Qiang;H. Adachi;Zhe Huang;Yue‐Mei Jiang;M. Katsuno;Makoto Minamiyama;H. Doi;Shin-jiro Matsumoto-Shin-j]
通讯作者: Qiang Qiang-Qiang;H. Adachi;Zhe Huang;Yue‐Mei Jiang;M. Katsuno;Makoto Minamiyama;H. Doi;Shin-jiro Matsumoto-Shin-j
球脊髄性筋萎縮症治療薬
脊髓和延髓性肌萎缩症治疗药物
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1002/ana.21540
发表时间: 2009-02-01
期刊: ANNALS OF NEUROLOGY
影响因子: 11.2
作者: [Banno, Haruhiko, Katsuno, Masahisa, Sobue, Gen]
通讯作者: Sobue, Gen
Effect of leuprorelin in patients with spinal and bulbar muscular atrophy (SBMA): a multicenter, randomized, double-blind, placebo-controlled trial.
亮丙瑞林对脊髓和延髓性肌萎缩症 (SBMA) 患者的影响:一项多中心、随机、双盲、安慰剂对照试验。
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Hanafusa N, Fujita T, et al., Banno H]
通讯作者: Banno H
56
    Therapeutic strategy of neurodegenerative disease using microRNA
    • 批准号:
      25670418
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      SOBUE Gen
    • 依托单位:
    Identification of therapeutic targets for ALS by screening for TDP-43 and FUS associated molecules
    • 批准号:
      23659452
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      SOBUE Gen
    • 依托单位:
    Pathogenesis-based therapy development for polyglutamine diseases
    • 批准号:
      19209033
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $32.61万
    • 财政年份:
      2007
    • 负责人:
      SOBUE Gen
    • 依托单位:
    Development of pathogenesis-based therapy for polyglutamine diseases
    • 批准号:
      17025020
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $106.94万
    • 财政年份:
      2005
    • 负责人:
      SOBUE Gen
    • 依托单位:
    海外基金